Jubilant Pharmova Limited Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹1022.6Market Cap
₹ 16,300 Cr.Stock P/E
37.3ROE
6.55 %RSI
75.84Trend
BullishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.[1]
Jubilant Pharmova Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Jubilant Pharmova Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Jubilant Pharmova Ltd share price chart currently indicates a Bullish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 1022.6 |
| RSI (14) | 75.84 |
| 50 DMA | 983.29 |
| 200 DMA | 994.48 |
| Trend | Bullish |
| A/D Rating | C |
| RS Rating | 49 |
| EPS Rating | 26 |
| TI65 | 1.02 |
| TI65 Trend | Neutral |
Pivot Points Analysis
Daily pivot points for Jubilant Pharmova Limited calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹1053.34 |
| R2 | ₹1040.17 |
| R1 | ₹1031.39 |
| PP | ₹1018.22 |
| S1 | ₹1009.44 |
| S2 | ₹996.27 |
| S3 | ₹987.49 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 16,300 Cr. |
| Current Price | ₹ 1,023 |
| High / Low | ₹ 1,250 / 784 |
| Stock P/E | 37.3 |
| Book Value | ₹ 445 |
| Dividend Yield | 0.49 % |
| ROCE | 8.99 % |
| ROE | 6.55 % |
| Face Value | ₹ 1.00 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Mar 2023 | 1,678 | -100 | 13% |
| Jun 2023 | 1,587 | 6 | 11% |
| Sep 2023 | 1,680 | 62 | 14% |
| Dec 2023 | 1,677 | 66 | 13% |
| Mar 2024 | 1,759 | -62 | 15% |
| Jun 2024 | 1,732 | 482 | 15% |
| Sep 2024 | 1,752 | 102 | 17% |
| Dec 2024 | 1,822 | 101 | 16% |
| Mar 2025 | 1,929 | 151 | 18% |
| Jun 2025 | 1,901 | 102 | 15% |
| Sep 2025 | 1,966 | 120 | 17% |
| Dec 2025 | 2,122 | 56 | 14% |
| Mar 2026 | 2,290 | 119 | 15% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 54.02% |
| FIIs | 20.70% |
| DIIs | 3.72% |
| Public | 19.32% |
| Others | 2.23% |
| No. of Shareholders | 36,546 |
| Government | 0.00% |
Pros and Cons
Pros
- Aggressive price velocity driving asset values comfortably higher above the 50 DMA (983.29).
Cons
Related NSE Stocks
National Aluminium Company Limited
View Share Price Analysis →Caplin Point Laboratories Limited
View Share Price Analysis →United Spirits Limited
View Share Price Analysis →Cholamandalam Financial Holdings Limited
View Share Price Analysis →Solar Industries India Limited
View Share Price Analysis →DCM Shriram Limited
View Share Price Analysis →Supreme Petrochem Limited
View Share Price Analysis →Garden Reach Shipbuilders & Engineers Limited
View Share Price Analysis →Steel Authority of India Limited
View Share Price Analysis →Devyani International Limited
View Share Price Analysis →Astral Limited
View Share Price Analysis →Swiggy Limited
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Jubilant Pharmova Ltd share?
Based on the latest closing data, the technical momentum for Jubilant Pharmova Ltd is currently evaluated as Bullish. The stock is exhibiting an RSI (14) of 75.84, indicating it is trading in a technically overbought zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (983.29) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Jubilant Pharmova Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Jubilant Pharmova Ltd today centers at a Pivot Point (PP) of ₹1018.22. Upside resistance challenges are calculated at R1: ₹1031.39, R2: ₹1040.17, and R3: ₹1053.34. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹1009.44, S2: ₹996.27, and S3: ₹987.49.
How does the fundamental ROE and P/E ratio look for Jubilant Pharmova Ltd?
Jubilant Pharmova Ltd is currently trading with a valuation metrics context of a Stock P/E of 37.3, against a core structural efficiency Return on Equity (ROE) standing at 6.55 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 26, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Jubilant Pharmova Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Short-Term Momentum Caution (Hold / Overbought Climax). While Jubilant Pharmova ... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of C, a Relative Strength (RS) ranking of 48, and long-term trend backing from the TI65 indicator (Neutral pattern).